首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits.
【24h】

Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits.

机译:虎杖何首乌苷对高脂血症家兔血脂的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hyperlipidemia is one of the vital coronary risk factors and is positively related to morbidity and mortality of coronary heart disease. There are numerous herbal medicines which are reported to exert good hypolipidemic actions with few side effects. In the present study, the hypolipidemic effects of polydatin, a compound from Polygonum cuspidatum Sieb. et Zucc, on hyperlipidemic rabbits were evaluated. Thirty-two male rabbits were fed a high fat/cholesterol diet for 6 weeks and another eight male rabbits fed a basic diet served as normal control. Three weeks after a high fat/cholesterol diet, the animals were orally administrated polydatin (25, 50, and 100 mg kg(-1) per day) by intubation for 3 weeks. The results showed that polydatin markedly decreased the serum levels of total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) in hyperlipidemic rabbits. The ratio of TC to high-density lipoprotein cholesterol (HDL-C) and the liver coefficient were also reduced. But both polydatin and high fat/cholesterol diet did not evidently affect body weight in hyperlipidemic rabbits. All these results suggest that polydatin from Polygonum cuspidatum has favorable potency to develop a hypolipemic and/or hepatoprotective agent in clinic. However the mechanism of hypolipemic action of polydatin is in need of further clarity.
机译:高脂血症是重要的冠心病危险因素之一,与冠心病的发病率和死亡率呈正相关。据报道,许多草药具有良好的降血脂作用,几乎没有副作用。在本研究中,虎杖中的一种化合物白藜芦醇苷的降血脂作用。 et al Zucc,对高脂血症兔子进行了评估。给32只雄性兔子喂高脂/胆固醇饮食6周,另外8只雄性兔子喂食基本饮食作为正常对照。高脂/胆固醇饮食三周后,通过插管法给动物口服多巴定(每天25、50和100 mg kg(-1)),持续3周。结果表明,白藜芦醇苷可明显降低高脂血症兔的血清总胆固醇(TC),甘油三酸酯(TG)和低密度脂蛋白胆固醇(LDL-C)。 TC与高密度脂蛋白胆固醇(HDL-C)的比例和肝系数也降低了。但是,在高脂血症兔子中,聚拉丁汀和高脂/胆固醇饮食都没有明显影响体重。所有这些结果表明,虎杖中的白藜芦醇苷在临床上具有开发降血脂和/或肝保护剂的有利作用。但是,多肽的降血脂作用机理尚需进一步阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号